SCHEMBL8560241

SCHEMBL8560241

CCC([C]=O)C(=O)ON1C(=O)CCC1=O

nearest known ligand 0.32

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA3 P07451 1/20 0.32
CA4 P22748 1/20 0.32
CA6 P23280 1/20 0.32
CA5A P35218 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32
CA13 Q8N1Q1 1/20 0.32
CA14 Q9ULX7 1/20 0.32
CA5B Q9Y2D0 1/20 0.32
ALDH1A1 P00352 1/20 0.31
KMT2A Q03164 2/20 0.31
MGLL Q99685 1/20 0.31
MEN1 O00255 1/20 0.31
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12048292 0.79 CA1 (0.35) LMNACA12CA1CA2CA3
SCHEMBL16133577 0.77 MGLL (0.35) LMNACA12CA1CA2CA3
SCHEMBL1480734 0.77 ALDH1A1 (0.34) LMNACA12CA1CA2CA3
SCHEMBL261924 0.77 MGLL (0.35) LMNACA12CA1CA2CA3
SCHEMBL327689 0.75 KMT2A (0.33) LMNACA12CA1CA2CA3
SCHEMBL13441949 0.75 LMNA (0.39) LMNACA12CA1CA2CA3
SCHEMBL1202780 0.73 MGLL (0.33) LMNACA12CA1CA2CA3
SCHEMBL1024247 0.73 MGLL (0.33) LMNACA12CA1CA2CA3
Ethylene Glycol SCHEMBL2153229 0.73 MGLL (0.33) LMNACA12CA1CA2CA3
SCHEMBL19962869 0.73 CA2 (0.40) LMNACA12CA1CA2CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0863881-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE IN THE PREVENTION AND/OR THE TREATMENT OF BONE DISEASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-09-16 EP disclosed
WO-1997010219-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE IN THE PREVENTION AND/OR THE TREATMENT OF BONE DISEASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-03-20 WO disclosed